Market By Products, Applications, End-users And Geography | Forecast 2019-2027
The Europe immunohistochemistry market is expected to display an upward trend and is estimated to grow at a CAGR of 7.06% during the forecast years of 2019-2027.
Countries covered in the Europe immunohistochemistry market are:
• United Kingdom
• Germany
• France
• Italy
• Spain
• Russia
• Rest of Europe
To get detailed insights on segments, Download Sample Report
The prevalence of cardiovascular diseases mainly in the semi-urban and urban counties of the United Kingdom is escalating the demand and growth of the immunohistochemistry market in the country. Cardiovascular diseases include all kinds of conditions from the ones diagnosed at birth or inherited to those developed conditions which include atrial fibrillation, stroke, heart failure, and heart disease. The constant rise in the ageing & growing population and the improved survival rates caused due to cardiovascular diseases may escalate these numbers considering the forthcoming future.
The immunohistochemistry market has a promising growth in France primarily due to the increasing prevalence of cancer and the rising expenditure on healthcare. Healthcare expenditure and financing in France is also increasing, which is expected to positively impact the immunohistochemistry market in the country. The Spain immunohistochemistry market would be positively impacted, taking into consideration the future scenario as the constant rise in the prevalence of diabetes mellitus in the country is further augmenting the demand and growth of the immunohistochemistry market.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. EUROPE
IMMUNOHISTOCHEMISTRY MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. MARKET
DEFINITION
2.2. HISTORY
OF IMMUNOHISTOCHEMISTRY
2.3. VALUE
CHAIN OUTLOOK
2.4. KEY
INSIGHTS
2.5. MARKET
ATTRACTIVENESS MATRIX
2.6. MARKET
DRIVERS
2.6.1. IN-VITRO
TECHNOLOGICAL ADVANCEMENTS
2.6.2. INCREASING
OCCURRENCE OF CANCER
2.6.3. SWELLING
HEALTHCARE SPENDING
2.6.4. INCREASING
USE OF POC TESTING
2.7. MARKET
RESTRAINTS
2.7.1. RESTRICTIONS
OF CLOSED SYSTEMS
2.7.2. REIMBURSEMENT
ISSUES
2.8. MARKET
OPPORTUNITIES
2.8.1. INCREASING
USE OF BIOMARKERS FOR DISEASE DIAGNOSIS
2.8.2. TECHNOLOGICAL
ADVANCEMENTS
2.9. MARKET
CHALLENGES
2.9.1. STRINGENT
REGULATIONS
2.9.2. HIGH
MAINTENANCE COST INFLUENCING THE MARKET GROWTH
3. IMMUNOHISTOCHEMISTRY
(IHC) MARKET OUTLOOK - BY PRODUCTS
3.1. ANTIBODIES
3.1.1. PRIMARY
ANTIBODIES
3.1.2. SECONDARY
ANTIBODIES
3.2. EQUIPMENT
3.2.1. SLIDE
STAINING SYSTEMS
3.2.2. TISSUE
MICROARRAYS
3.2.3. TISSUE
PROCESSING SYSTEMS
3.2.4. SLIDE
SCANNERS
3.2.5. OTHER
EQUIPMENT
3.3. REAGENTS
3.3.1. HISTOLOGICAL
STAINS
3.3.2. BLOCKING
SERA AND REAGENTS
3.3.3. CHROMOGENIC
SUBSTRATES
3.3.4. FIXATION
REAGENTS
3.3.5. STABILIZERS
3.3.6. ORGANIC
SOLVENTS
3.3.7. PROTEOLYTIC
ENZYMES
3.3.8. DILUENTS
3.4. KITS
4. IMMUNOHISTOCHEMISTRY
(IHC) MARKET OUTLOOK - BY APPLICATIONS
4.1. DIAGNOSTICS
4.1.1. CANCER
4.1.2. INFECTIOUS
DISEASES
4.1.3. CARDIOVASCULAR
DISEASE
4.1.4. AUTOIMMUNE
DISEASES
4.1.5. DIABETES
MELLITUS
4.1.6. NEPHROLOGICAL
DISEASES
4.2. DRUG
TESTING
5. IMMUNOHISTOCHEMISTRY
(IHC) MARKET OUTLOOK - BY END-USERS
5.1. HOSPITALS
AND DIAGNOSTIC LABORATORIES
5.2. RESEARCH
INSTITUTES
5.3. OTHER
END-USERS
6. IMMUNOHISTOCHEMISTRY
(IHC) MARKET - EUROPE
6.1. COUNTRY
ANALYSIS
6.1.1. THE
UNITED KINGDOM
6.1.2. FRANCE
6.1.3. GERMANY
6.1.4. SPAIN
6.1.5. ITALY
6.1.6. RUSSIA
6.1.7. REST
OF EUROPE
7. COMPETITIVE
LANDSCAPE
7.1. ABBOTT
LABORATORIES
7.2. ABCAM
PLC
7.3. AGILENT
TECHNOLOGIES, INC.
7.4. BIOGENEX
7.5. BIO-RAD
LABORATORIES, INC.
7.6. BIO
SB
7.7. CELL
SIGNALING TECHNOLOGY, INC.
7.8. DANAHER
CORPORATION
7.9. F.
HOFFMANN-LA ROCHE AG
7.10.
HISTOLOGIX
7.11.
MERCK MILLIPORE
7.12.
PERKINELMER, INC.
7.13.
SIEMENS AG HEALTHCARE
7.14.
THERMO FISHER SCIENTIFIC, INC.
8. METHODOLOGY
AND SCOPE
8.1. RESEARCH
SCOPE
8.2. SOURCES
OF DATA
8.3. RESEARCH
METHODOLOGY
TABLE 1 EUROPE MARKET FOR IMMUNOHISTOCHEMISTRY
2019-2027 ($ MILLION)
TABLE 2 CANCER MARKERS USED IN DIAGNOSIS AND
TREATMENT
TABLE 3 EUROPE IMMUNOHISTOCHEMISTRY MARKET BY
PRODUCTS 2019-2027 ($ MILLION)
TABLE 4 EUROPE IMMUNOHISTOCHEMISTRY MARKET IN
ANTIBODIES BY TYPE 2019-2026 ($ MILLION)
TABLE 5 CLINICALLY IMPORTANT MONOCLONAL
ANTIBODIES
TABLE 6 SECONDARY ANTIBODY SELECTION
TABLE 7 EUROPE IMMUNOHISTOCHEMISTRY MARKET IN
EQUIPMENT BY TYPES 2019-2027 ($ MILLION)
TABLE 8 EUROPE IMMUNOHISTOCHEMISTRY MARKET IN
REAGENTS BY TYPE 2019-2027 ($ MILLION)
TABLE 9 HISTOLOGY STAINS AND ITS CATEGORIES
TABLE 10 COMMON FIXATIVES AND THEIR GENERAL TARGET
ANTIGENS
TABLE 11 EUROPE IMMUNOHISTOCHEMISTRY MARKET IN KITS
2019-2027 ($ MILLION)
TABLE 12 KIT COMPONENTS ARE AVAILABLE FOR IHC
OPTIMIZATION
TABLE 13 EUROPE IMMUNOHISTOCHEMISTRY MARKET BY
APPLICATION 2019-2027 ($ MILLION)
TABLE 14 EUROPE IMMUNOHISTOCHEMISTRY MARKET IN DIAGNOSTICS
BY TYPE 2019-2027 ($ MILLION)
TABLE 15 SELECTED INFECTIOUS ETIOLOGIES OF
AUTOIMMUNE DISEASES
TABLE 16 EUROPE IMMUNOHISTOCHEMISTRY MARKET BY END-USERS
2019-2027 ($ MILLION)
TABLE 17 NUMBER OF PEOPLE LIVING AND DYING WITH CVD
TABLE 18 NUMBER OF DEATHS CAUSED BY CARDIOVASCULAR
DISEASES IN GERMANY 2016
TABLE 19 DISEASES CAUSING PREMATURE DEATH IN
GERMANY 2017
FIGURE 1 EUROPE MARKET FOR IMMUNOHISTOCHEMISTRY
2019-2027 ($ MILLION)
FIGURE 2 HISTORY OF IMMUNOHISTOCHEMISTRY
FIGURE 3 EUROPE IMMUNOHISTOCHEMISTRY MARKET IN
ANTIBODIES 2019-2027 ($ MILLION)
FIGURE 4 EUROPE ANTIBODIES MARKET IN PRIMARY
ANTIBODIES 2019-2027 ($ MILLION)
FIGURE 5 EUROPE ANTIBODIES MARKET IN SECONDARY
ANTIBODIES 2019-2027 ($ MILLION)
FIGURE 6 EUROPE IMMUNOHISTOCHEMISTRY MARKET IN
EQUIPMENT 2019-2027 ($ MILLION)
FIGURE 7 EUROPE EQUIPMENT MARKET IN SLIDE STAINING
SYSTEMS 2019-2027 ($ MILLION)
FIGURE 8 EUROPE EQUIPMENT MARKET IN TISSUE
MICROARRAYS 2019-2027 ($ MILLION)
FIGURE 9 EUROPE EQUIPMENT MARKET IN TISSUE
PROCESSING SYSTEMS 2019-2027 ($ MILLION)
FIGURE 10 EUROPE EQUIPMENT MARKET IN SLIDE SCANNERS
2019-2027 ($ MILLION)
FIGURE 11 EUROPE EQUIPMENT MARKET IN OTHER EQUIPMENT
2019-2027 ($ MILLION)
FIGURE 12 EUROPE IMMUNOHISTOCHEMISTRY MARKET IN
REAGENTS 2019-2027 ($ MILLION)
FIGURE 13 EUROPE REAGENTS MARKET IN HISTOLOGICAL STAINS
2019-2027 ($ MILLION)
FIGURE 14 EUROPE REAGENTS MARKET IN BLOCKING SERA AND
REAGENTS 2019-2027 ($ MILLION)
FIGURE 15 EUROPE REAGENTS MARKET IN CHROMOGENIC
SUBSTRATES 2019-2027 ($ MILLION)
FIGURE 16 EUROPE REAGENTS MARKET IN FIXATION REAGENTS
2019-2027 ($ MILLION)
FIGURE 17 EUROPE REAGENTS MARKET IN STABILIZERS
2019-2027 ($ MILLION)
FIGURE 18 EUROPE REAGENTS MARKET IN ORGANIC SOLVENTS
2019-2027 ($ MILLION)
FIGURE 19 EUROPE REAGENTS MARKET IN PROTEOLYTIC ENZYMES
2019-2027 ($ MILLION)
FIGURE 20 EUROPE REAGENTS MARKET IN DILUENTS 2019-2027
($ MILLION)
FIGURE 21 PHASES OF HISTOLOGICAL STAINING
FIGURE 22 EUROPE IMMUNOHISTOCHEMISTRY MARKET IN KITS
2019-2027 ($ MILLION)
FIGURE 23 EUROPE IMMUNOHISTOCHEMISTRY MARKET IN DIAGNOSTICS
2019-2027 ($ MILLION)
FIGURE 24 EUROPE DIAGNOSTICS MARKET IN CANCER 2019-2027
($ MILLION)
FIGURE 25 EUROPE DIAGNOSTICS MARKET IN INFECTIOUS
DISEASES 2019-2027 ($ MILLION)
FIGURE 26 EUROPE DIAGNOSTICS MARKET IN CARDIOVASCULAR
DISEASE 2019-2027 ($ MILLION)
FIGURE 27 EUROPE DIAGNOSTICS MARKET IN AUTOIMMUNE
DISEASES 2019-2027 ($ MILLION)
FIGURE 28 EUROPE DIAGNOSTICS MARKET IN DIABETES
MELLITUS 2019-2027 ($ MILLION)
FIGURE 29 EUROPE DIAGNOSTICS MARKET IN NEPHROLOGICAL
DISEASES 2019-2027 ($ MILLION)
FIGURE 30 EUROPE IMMUNOHISTOCHEMISTRY MARKET IN DRUG
TESTING 2019-2027 ($ MILLION)
FIGURE 31 EUROPE IMMUNOHISTOCHEMISTRY MARKET IN
HOSPITALS AND DIAGNOSTIC LABORATORIES 2019-2027 ($ MILLION)
FIGURE 32 EUROPE IMMUNOHISTOCHEMISTRY MARKET IN
RESEARCH INSTITUTES 2019-2027 ($ MILLION)
FIGURE 33 EUROPE IMMUNOHISTOCHEMISTRY MARKET IN OTHER END-USERS
2019-2027 ($ MILLION)
FIGURE 34 THE UNITED KINGDOM IMMUNOHISTOCHEMISTRY
MARKET 2019-2027 ($ MILLION)
FIGURE 35 FRANCE IMMUNOHISTOCHEMISTRY MARKET 2019-2027
($ MILLION)
FIGURE 36 GERMANY IMMUNOHISTOCHEMISTRY MARKET 2019-2027
($ MILLION)
FIGURE 37 SPAIN IMMUNOHISTOCHEMISTRY MARKET 2019-2027
($ MILLION)
FIGURE 38 ITALY IMMUNOHISTOCHEMISTRY MARKET 2019-2027
($ MILLION)
FIGURE 39 RUSSIA IMMUNOHISTOCHEMISTRY MARKET 2019-2027
($ MILLION)
FIGURE 40 REST OF EUROPE IMMUNOHISTOCHEMISTRY MARKET
2019-2027 ($ MILLION)